FOXM1 and gastric cancer: In this study, we demonstrated that the expression of FOXM1 mediated the resistance to docetaxel in gastric cancer cells, for which elevated levels of FOXM1 was shown to correlate with lower drug susceptibility, whereas the molecular evolution assay of AGS resulted in significantly more resistant cells possessed FOXM1 overexpression.